ARK Diagnostics Announces New Drug Testing Assays In Development
Fremont, CA — ARK Diagnostics, Inc. is pleased to announce the development of four new homogeneous enzyme immunoassays. Each assay is offered in a convenient, liquid-stable, ready-to-use format and is optimized for use on a wide range of fully automated clinical chemistry analyzers.
ARK Fentanyl Plus Assay
ARK Ketamine II Assay
ARK Meprobamate Assay
ARK Buprenorphine Assay
These products are currently under development. Not FDA cleared for sale in the United States.
About ARK Diagnostics
ARK Diagnostics, Inc. is a leading developer and manufacturer of high-quality in vitro diagnostic reagents for clinical laboratories worldwide. Headquartered in Fremont, California, ARK specializes in innovative homogeneous enzyme immunoassays designed for automated chemistry analyzers.
Contact Information
ARK Diagnostics, Inc.
48089 Fremont Blvd.
Fremont, California, 94538
877-869-2320
sales@ark-tdm.com
www.ark-tdm.com
To learn more visit www.ark-tdm.com or email sales@ark-tdm.com
ARK Fentanyl Plus Assay
ARK Ketamine II Assay
ARK Meprobamate Assay
ARK Buprenorphine Assay
These products are currently under development. Not FDA cleared for sale in the United States.
ARK Diagnostics, Inc. is a leading developer and manufacturer of high-quality in vitro diagnostic reagents for clinical laboratories worldwide. Headquartered in Fremont, California, ARK specializes in innovative homogeneous enzyme immunoassays designed for automated chemistry analyzers.
Contact Information
ARK Diagnostics, Inc.
48089 Fremont Blvd.
Fremont, California, 94538
877-869-2320
sales@ark-tdm.com
www.ark-tdm.com
To learn more visit www.ark-tdm.com or email sales@ark-tdm.com
Category Press Releases